Assay Detail
Functional
CHEMBL4822422
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human U-251 cells by MTT assay
13
Total Activities
13
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | U-251 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Chemical modifications of ergostane-type triterpenoids from Antrodia camphorata and their cytotoxic activities.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 13 | 4.66 | 5.54 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4853017 | — | — | 1 | 5.54 |
| CHEMBL4848965 | — | — | 1 | 5.48 |
| CHEMBL4857161 | — | — | 1 | 4.98 |
| CHEMBL4846052 | — | — | 1 | 4.77 |
| CHEMBL4875885 | — | — | 1 | 4.56 |
| CHEMBL810 | TEMOZOLOMIDE | 4.0 | 1 | 4.44 |
| CHEMBL4867882 | — | — | 1 | 4.08 |
| CHEMBL4865243 | — | — | 1 | 4.03 |
| CHEMBL4854932 | — | — | 1 | 4.02 |
| CHEMBL4863216 | — | — | 1 | - |
| CHEMBL4862316 | — | — | 1 | - |
| CHEMBL428647 | PACLITAXEL | 4.0 | 1 | - |
| CHEMBL481 | IRINOTECAN | 4.0 | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4853017 | — | IC50 | = | 2900.0 | nM | 5.54 |
| CHEMBL4848965 | — | IC50 | = | 3300.0 | nM | 5.48 |
| CHEMBL4857161 | — | IC50 | = | 10400.0 | nM | 4.98 |
| CHEMBL4846052 | — | IC50 | = | 17100.0 | nM | 4.77 |
| CHEMBL4875885 | — | IC50 | = | 27400.0 | nM | 4.56 |
| CHEMBL810 | TEMOZOLOMIDE | IC50 | = | 36400.0 | nM | 4.44 |
| CHEMBL4867882 | — | IC50 | = | 82400.0 | nM | 4.08 |
| CHEMBL4865243 | — | IC50 | = | 93200.0 | nM | 4.03 |
| CHEMBL4854932 | — | IC50 | = | 95800.0 | nM | 4.02 |
| CHEMBL4863216 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL4862316 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL428647 | PACLITAXEL | IC50 | - | — | - | |
| CHEMBL481 | IRINOTECAN | IC50 | - | — | - |